Obesity can cause a host of health problems, including various cancers, coronary heart disease, high blood pressure, stroke, Type 2 diabetes, sleep apnea and more
Tirzepatide, a dual glucagon-like peptide-1 (GIP) and GLP-1RAs, administered once weekly at a 15 mg dose, resulted in an average weight loss of 20.9% over 72 weeks (Jastreboff et al., 2022), driven by its synergistic effects on appetite regulation, energy intake reduction, and fat mass decrease (Heise et al., 2023)
This combination will make to improve your skin glowing and whitening, and also work to reduce dark spots, oily skin, below are the few reasons to choose this rediclinic supplement
So maybe the drug needs to be used in combination with a sensible diet and exercise regime, if the weight is to stay off